Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 5Recruiting 4Terminated 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Head and Neck Neoplasms 276Squamous Cell Carcinoma of Head and Neck 241Carcinoma, Non-Small-Cell Lung 86Melanoma 68Neoplasms 61Colorectal Neoplasms 52Neoplasm Metastasis 48Carcinoma, Squamous Cell 48Thyroid Neoplasms 47Breast Neoplasms 41Carcinoma, Renal Cell 36Lung Neoplasms 34Ovarian Neoplasms 33Oropharyngeal Neoplasms 30Stomach Neoplasms 29Mouth Neoplasms 29Nasopharyngeal Carcinoma 28Triple Negative Breast Neoplasms 26Uterine Cervical Neoplasms 25Sarcoma 25Laryngeal Neoplasms 24Pancreatic Neoplasms 23Esophageal Neoplasms 23Salivary Gland Neoplasms 21Urinary Bladder Neoplasms 20Recurrence 19Nasopharyngeal Neoplasms 18Small Cell Lung Carcinoma 17Carcinoma, Transitional Cell 17Prostatic Neoplasms 16

Interventions

motexafin gadolinium 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Tonsillar Neoplasms × Head & Neck × Clear all
NCT00080028 2007-05-08

Motexafin Gadolinium With Chemotherapy and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer

Pharmacyclics LLC.

Phase 1 Terminated
18 enrolled
Head & Neck

Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Oropharyngeal Neoplasms, Tonsillar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡